603108 Shanghai Runda Medical Technology
- 18.23
- +0.17+0.94%
Shanghai Runda Medical Technology News
How Did Shanghai Runda Medical Technology Co., Ltd.'s (SHSE:603108) 6.7% ROE Fare Against The Industry?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). To keep the less
Runda Healthcare (603108.SH): Net profit of 22.6038 million yuan in the first quarter decreased by 72.11% year-on-year
On April 27, Ge Longhui (603108.SH) released its report for the first quarter of 2024, achieving operating income of 2,072 billion yuan, a year-on-year decrease of 4.85%; net profit attributable to shareholders of listed companies of 22.6038 million yuan, a year-on-year decrease of 72.11%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses of 18.60.26 million yuan, a year-on-year decrease of 74.27%; and basic earnings per share of 0.04 yuan.
Runda Healthcare (603108.SH) announced first-quarter results, net profit of 22.6 million yuan, a year-on-year decrease of 72.11%
Runda Healthcare (603108.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 20 during the reporting period...
More Unpleasant Surprises Could Be In Store For Shanghai Runda Medical Technology Co., Ltd.'s (SHSE:603108) Shares After Tumbling 25%
The Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) share price has softened a substantial 25% over the previous 30 days, handing back much of the gains the stock has made lately. Still,
Does Shanghai Runda Medical Technology (SHSE:603108) Deserve A Spot On Your Watchlist?
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. But as Peter Lynch said in One Up On Wall
The Market Lifts Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) Shares 31% But It Can Do More
Those holding Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) shares would be relieved that the share price has rebounded 31% in the last thirty days, but it needs to keep going to repair th
How Good Is Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108), When It Comes To ROE?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. By way of learning
Shanghai Runda Medical Technology (SHSE:603108) Sheds 7.6% This Week, as Yearly Returns Fall More in Line With Earnings Growth
Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) shareholders might be concerned after seeing the share price drop 17% in the last month. But that doesn't change the fact that the returns
Investors Give Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) Shares A 25% Hiding
Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) shareholders won't be pleased to see that the share price has had a very rough month, dropping 25% and undoing the prior period's positive per
If EPS Growth Is Important To You, Shanghai Runda Medical Technology (SHSE:603108) Presents An Opportunity
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Unfortunately, these high risk investments
These 4 Measures Indicate That Shanghai Runda Medical Technology (SHSE:603108) Is Using Debt Extensively
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
Did Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) Use Debt To Deliver Its ROE Of 11%?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). We'll use ROE to
GLONGHUI ANNOUNCEMENT SELECTION | Sino-Bei Communications: The proposed investment of 5.5 billion yuan to build a base in East China mainly includes a low-carbon AI computing power center and high-efficiency power and energy storage battery PACK projects
[Hot Focus] Shenglong Co., Ltd. (603178.SH): Products used in new energy vehicles account for a smaller proportion of the company's revenue, Shenglong Co., Ltd. (603178.SH) announced that the cumulative increase in the closing price of the company's stock since September 27, 2023 was 34.39%. The average increase in Shenwan's auto parts industry during the same period was 2.50%. The short-term increase in the company's stock was seriously higher than the industry increase and the Shanghai Stock Exchange Index. There is a situation where market sentiment is too hot. The closing price of the company's stock rose and stopped on 4 of the 5 trading days from September 27 to October 11, but the company's fundamentals did not occur
Runda Healthcare (603108.SH): Xiaohui, a large model jointly developed and launched with HUAWEI CLOUD, is currently in closed beta in the early stages of official commercialization
Glonghui, Oct. 11, 丨 Runda Healthcare (603108.SH) announced that regarding the company's cooperation with HUAWEI CLOUD (HUAWEI CLOUD for short), there is commercial cooperation between the company and HUAWEI Cloud Computing Technology Co., Ltd. (HUAWEI CLOUD for short). Xiaohui, a big model jointly developed and launched by the two parties, is currently in closed beta in the early stages of formal commercialization. There is no signed customer yet, and there is uncertainty about subsequent customer development and contracts.
Shanghai Runda Medical Technology's (SHSE:603108) Five-year Earnings Growth Trails the 15% YoY Shareholder Returns
Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make significant gains if you buy good quality businesses at the right price. To wit
Dragon Tiger list丨Runda Medical rose and stopped, Tianfeng Securities Shenzhen Branch made a net purchase of 141 million yuan
Runda Healthcare (603108.SH) rose and stopped today, with a turnover rate of 12.25% and a turnover of 1.05 billion yuan. According to data from the Dragon Tiger List, the Shenzhen branch of Tianfeng Securities bought one seat, with a net purchase of 141 million yuan; Shanghai Stock Connect bought 52.2724 million yuan and sold 26.930,800 yuan at the same time, with a net purchase of 253.416 million yuan; one institution sold two seats, with a net sale of 26.404 million yuan.
Runda Healthcare (603108.SH): Currently, the depression detection products developed by the company are still in the development stage
GLONGHUI September 12丨Some investors asked Runda Healthcare (603108.SH): Business progress in the area of depression? I heard that it is possible to cooperate with education-related departments? Runda Medical Reply: Dear Investors! Currently, the depression testing products developed by the company are still in the development stage. Please pay attention to the information published on the company's official channels for related developments. Thank you for your interest.
Runda Healthcare (603108.SH): The company will continue to focus on its main business and steadily advance development
GLONGHUI, September 12丨Some investors asked Runda Healthcare (603108.SH) a question: Does the company have formed huge data assets that have been cleaned and desensitized belong to the company? Can it be commercialized? Thank you. Runda Medical Reply: Dear investors, the company will continue to focus on its main business and steadily advance development. Thank you for your suggestions and attention.
Runda Healthcare (603108.SH): The company will develop a large model of professional and credible healthcare
GLONGHUI, September 12丨An investor asked Runda Healthcare (603108.SH): Xiaohui, a good doctor created by the company and the Huawei Pangu model. When will the C-end be available to consumers and families of doctors and patients? Thank you, can you introduce the main features of the C-side? Runda Medical Reply: Dear Investors! Thank you for your interest and suggestions. For ordinary people on the C-end, the company will develop a professional and credible medical and health care model, provide the public with professional and credible interpretation of test results, scientific and accurate medical and health science popularization, and active and friendly health management, and provide scientific, personalized, and friendly health management services. Please continue
Here's Why We Think Shanghai Runda Medical Technology (SHSE:603108) Might Deserve Your Attention Today
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. But as Peter Lynch said in One Up On Wall S
Analysis
Price Target
No Data
